While research has shown that capillary refill time (CRT) is a sound, and advantageous, way to guide clinical resuscitation, the current subjective method of estimating CRT is unreliable and leads to poor diagnoses.
PeriFRL, ProMedix's digital capillary refill time sensor, makes an objective, repeatable measurement of circulatory function that supports early (and accurate) diagnosis across countless pathologies - such as sepsis, cardiogenic shock, dehydration and hemorrhage.
The 2021 Surviving Sepsis Guidelines recommends using capillary refill time to guide resuscitation as an adjunct to other measures of perfusion. CRT as a marker of patient decline is increasingly gaining clinical traction throughout multiple areas of medicine; following an ever-increasing industry bibliography of clinical and observational studies.
Already used in over 2K patient encounters (under IRB, at multiple teaching hospitals in the US) PeriFRL improves the speed and accuracy of circulatory dysfunction monitoring by providing a reliable and accurate, digital CRT, which is a marker of distal perfusion.
ProMedix "PeriFRL" connects via Bluetooth to a mobile application that guides the user through pressure application and release. Results are conveyed via the mobile application to a secure server, or to a partner organization's patient monitoring platform. PeriFRL is affordable and requires little training; it is simple enough that it can even be used in home-health as well as in austere, nonclinical settings (such as in the field, or with EMS).
ProMedix is led by renowned clinical professionals who saw the need for improvement in the critical care space and decided to make a change.
ProMedix is backed by industrial and institutional leaders who see the value in novel medical technologies. We are supported by multiple organizations who provide valuable mentorship, capital, and connections with world class professionals.